CD19-Directed Monoclonal Antibodies
- Name
- CD19-Directed Monoclonal Antibodies
- Accession Number
- DBCAT005666
- Description
Monoclonal antibody directed against the B-cell-specific membrane protein CD19 with potential immunostimulating and antineoplastic activities.
- Drugs
Drug Drug Description Loncastuximab tesirine An antibody-drug conjugate used for the treatment of relapsed and refractory B-cell lymphomas. - Drugs & Drug Targets
Drug Target Type Loncastuximab tesirine B-lymphocyte antigen CD19 target Loncastuximab tesirine P-glycoprotein 1 transporter Loncastuximab tesirine Cytochrome P450 3A4 enzyme Loncastuximab tesirine Cytochrome P450 3A5 enzyme